News
The company also encounters competitive risks from other organizations developing therapies for chronic kidney disease.
MarketWatch on MSN14h
Microsoft’s stock gets an upgrade. Why these analysts say it’s underappreciated in AI.Microsoft Corp.’s stock was upgraded on Wednesday by analysts who expect investor interest in the company’s ...
Unlike conventional hyperscalers like Amazon’s AWS or Microsoft's Azure that provide a wide range of general-purpose cloud ...
Fed minutes and copper are in focus Wednesday as stocks look to shake of tariff anxiety and rally to fresh record highs.
Federal Housing Finance Agency director Bill Pulte announced that lenders may start using VantageScore, a rival to the Fair ...
U.S. stock indexes were buoyed on Wednesday by AI confidence thanks to Nvidia (NVDA.O), which became the first company to ...
Admittedly, in the relative near term, it’s difficult to frame U stock as cheap. In the past 52 weeks, for example, the ...
Stock futures are pointing to a slightly higher open on Wednesday after a sluggish start to the week amid uncertainty about U ...
According to the complaint filed in U.S. District Court for the Northern District of California, Bal was an early investor in ...
The scam revolves around a "ramp-and-dump" scheme that targets people through unsolicited investment club offers.
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...
Tesla stock price fell Monday after Musk said he's formed the America Party, the latest development in the billionaire's feud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results